Cargando…

Recent advances and future prospects in choroideremia

Choroideremia is a complex and rare disease that is frequently misdiagnosed due to its similar appearance to classic retinitis pigmentosa. Recent advances in genetic testing have identified specific genetic mutations in many retinal dystrophies, and the identification of the mutation of the CHM gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Zinkernagel, Martin S, MacLaren, Robert E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664510/
https://www.ncbi.nlm.nih.gov/pubmed/26648685
http://dx.doi.org/10.2147/OPTH.S65732
_version_ 1782403435611553792
author Zinkernagel, Martin S
MacLaren, Robert E
author_facet Zinkernagel, Martin S
MacLaren, Robert E
author_sort Zinkernagel, Martin S
collection PubMed
description Choroideremia is a complex and rare disease that is frequently misdiagnosed due to its similar appearance to classic retinitis pigmentosa. Recent advances in genetic testing have identified specific genetic mutations in many retinal dystrophies, and the identification of the mutation of the CHM gene on the X chromosome 25 years ago has paved the way for gene replacement therapy with the first human trials now underway. This article reviews the epidemiological and pathological features of choroideremia and new prospects in imaging to monitor disease progression, as well as potential treatment approaches for choroideremia.
format Online
Article
Text
id pubmed-4664510
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-46645102015-12-08 Recent advances and future prospects in choroideremia Zinkernagel, Martin S MacLaren, Robert E Clin Ophthalmol Review Choroideremia is a complex and rare disease that is frequently misdiagnosed due to its similar appearance to classic retinitis pigmentosa. Recent advances in genetic testing have identified specific genetic mutations in many retinal dystrophies, and the identification of the mutation of the CHM gene on the X chromosome 25 years ago has paved the way for gene replacement therapy with the first human trials now underway. This article reviews the epidemiological and pathological features of choroideremia and new prospects in imaging to monitor disease progression, as well as potential treatment approaches for choroideremia. Dove Medical Press 2015-11-23 /pmc/articles/PMC4664510/ /pubmed/26648685 http://dx.doi.org/10.2147/OPTH.S65732 Text en © 2015 Zinkernagel and MacLaren. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Zinkernagel, Martin S
MacLaren, Robert E
Recent advances and future prospects in choroideremia
title Recent advances and future prospects in choroideremia
title_full Recent advances and future prospects in choroideremia
title_fullStr Recent advances and future prospects in choroideremia
title_full_unstemmed Recent advances and future prospects in choroideremia
title_short Recent advances and future prospects in choroideremia
title_sort recent advances and future prospects in choroideremia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664510/
https://www.ncbi.nlm.nih.gov/pubmed/26648685
http://dx.doi.org/10.2147/OPTH.S65732
work_keys_str_mv AT zinkernagelmartins recentadvancesandfutureprospectsinchoroideremia
AT maclarenroberte recentadvancesandfutureprospectsinchoroideremia